{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:44:18Z","timestamp":1774712658779,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jphs.2015.11.008","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T12:31:36Z","timestamp":1449059496000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Nalfurafine hydrochloride, a selective \u03ba opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys"],"prefix":"10.1016","volume":"130","author":[{"given":"Kaoru","family":"Nakao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikito","family":"Hirakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie","family":"Kainoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Wakasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoji","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2015.11.008_bib1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/ndt\/gfp588","article-title":"Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study","volume":"25","author":"Kumagai","year":"2010","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jphs.2015.11.008_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000341268","article-title":"Efficacy and safety of a novel \u03ba-agonist for managing intractable pruritus in dialysis patients","volume":"36","author":"Kumagai","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jphs.2015.11.008_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1358\/dot.2009.45.5.1377595","article-title":"Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients","volume":"45","author":"Nakao","year":"2009","journal-title":"Drugs Today"},{"key":"10.1016\/j.jphs.2015.11.008_bib4","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","article-title":"\u03ba-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies","volume":"16","author":"Wikstr\u00f6m","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jphs.2015.11.008_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-2999(99)00369-6","article-title":"Pharmacological properties of TRK-820 on cloned \u03bc- , \u03b4- and \u03ba-opioid receptors and nociception receptor","volume":"376","author":"Seki","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2015.11.008_bib6","first-page":"547","article-title":"Opioid analgesics","volume":"11","author":"Gutstein","year":"2005"},{"key":"10.1016\/j.jphs.2015.11.008_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1037\/a0013088","article-title":"Mu\/kappa opioid interactions in rhesus monkeys: Implications for analgesia and abuse liability","volume":"16","author":"Negus","year":"2008","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.jphs.2015.11.008_bib8","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0024-3205(01)00957-2","article-title":"The novel \u03ba-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice","volume":"68","author":"Tsuji","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.jphs.2015.11.008_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-002-1028-z","article-title":"Effects of a newly synthesized \u03ba-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats","volume":"161","author":"Mori","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jphs.2015.11.008_bib10","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0376-8716(03)00099-1","article-title":"Principles of drug abuse liability assessment in laboratory animals","volume":"70","author":"Ator","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jphs.2015.11.008_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1527-3458.2005.tb00270.x","article-title":"Bremazocine: a \u03ba-opioid agonist with potent analgesic and other pharmacologic properties","volume":"11","author":"Dortch-Carnes","year":"2005","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.jphs.2015.11.008_bib12","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.drugalcdep.2009.04.003","article-title":"Principles of laboratory assessment of drug abuse liability and implications for clinical development","volume":"105S","author":"Carter","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jphs.2015.11.008_bib13","first-page":"1","article-title":"Prediction and prevention of prescription drug abuse: role of preclinical assessment of substance abuse liability","author":"Marusich","year":"2013","journal-title":"Methods Rep RTI Press"},{"key":"10.1016\/j.jphs.2015.11.008_bib14","first-page":"53","article-title":"Reinforcing effect as a function of infusion speed in intravenous self-administration of nicotine in rhesus monkeys","volume":"15","author":"Wakasa","year":"1995","journal-title":"Jpn J Psychopharmacol"},{"key":"10.1016\/j.jphs.2015.11.008_bib15","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0022-3565(24)29474-X","article-title":"GR89,696: a potent \u03ba-opioid agonist with subtype selectivity in rhesus monkeys","volume":"298","author":"Butelman","year":"2001","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2015.11.008_bib16","first-page":"352","article-title":"Relationship between doses that produce the reinforcing effect and gross behavioral effects in rhesus monkeys \u2013 2nd report","volume":"96","author":"Fujiwara","year":"2007"},{"key":"10.1016\/j.jphs.2015.11.008_bib17","first-page":"440","article-title":"Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications","volume":"178","author":"Toll","year":"1997","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.jphs.2015.11.008_bib18","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1016\/j.lfs.2004.05.033","article-title":"Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys","volume":"75","author":"Wakasa","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.jphs.2015.11.008_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.ps.40.020189.001203","article-title":"Brain dopamine and reward","volume":"40","author":"Wise","year":"1989","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.jphs.2015.11.008_bib20","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1523\/JNEUROSCI.11-09-02703.1991","article-title":"Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics","volume":"11","author":"Kuczenski","year":"1991","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jphs.2015.11.008_bib21","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","article-title":"Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common \u03bc1 opioid receptor mechanism","volume":"276","author":"Tanda","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jphs.2015.11.008_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/syn.890050104","article-title":"Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens","volume":"5","author":"Kalivas","year":"1990","journal-title":"Synapse"},{"key":"10.1016\/j.jphs.2015.11.008_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3565(25)23929-5","article-title":"Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol","volume":"239","author":"Imperato","year":"1986","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2015.11.008_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0014-2999(86)90629-1","article-title":"Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats","volume":"132","author":"Imperato","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2015.11.008_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-3565(24)37186-1","article-title":"Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in\u00a0vivo fast-cyclic voltammetry study","volume":"284","author":"Xi","year":"1998","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2015.11.008_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2009.08.013","article-title":"TRK-820, a selective kappa opioid receptor agonist, could effectively ameliorate L-DOPA-induced dyskinesia symptoms in a rat model of Parkinson's disease","volume":"620","author":"Ikeda","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2015.11.008_bib27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2009.01.043","article-title":"Effects of TRK-820, a selective kappa opioid receptor agonist, on rat schizophrenia models","volume":"606","author":"Yoshikawa","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2015.11.008_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01299-8","article-title":"Blockade of \u03bc-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice","volume":"461","author":"Mizoguchi","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2015.11.008_bib29","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0024-3205(99)00417-8","article-title":"Potent antinociceptive effects of TRK-820, a novel \u03ba-opioid receptor agonist","volume":"65","author":"Endoh","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.jphs.2015.11.008_bib30","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.2174\/138161281942140105165011","article-title":"Essential structure of the \u03ba opioid receptor agonist nalfurafine for binding to the \u03ba receptor","volume":"19","author":"Nagase","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jphs.2015.11.008_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/jpet.108.143925","article-title":"Effects of atypical \u03ba-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates","volume":"328","author":"Ko","year":"2009","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2015.11.008_bib32","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.lfs.2004.05.017","article-title":"Differential properties between TRK-820 and U-50,488H on the discriminative stimulus effects in rats","volume":"75","author":"Mori","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.jphs.2015.11.008_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-008-1458-3","article-title":"Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats","volume":"203","author":"Baker","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jphs.2015.11.008_bib34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.5414\/CP201852","article-title":"One year long-term study on abuse liability of nalfurafine in hemodialysis patients","volume":"51","author":"Ueno","year":"2013","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861315002303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861315002303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T16:53:57Z","timestamp":1748710437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861315002303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1347861315002303"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2015.11.008","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nalfurafine hydrochloride, a selective \u03ba opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2015.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}